EI
ETNB

Ellevest Inc’s 89bio ETNB Stock Holding History

Ellevest Inc’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3
Closed – – 1482
2021
Q3 		$0 Buy
+3
New +$55 ﹤0.01% 1451

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ellevest Inc's ETNB Position: Q4 2021 in Review

Ellevest Inc sold out of 89bio (ETNB) in Q4 2021, closing a stake of 3 shares.

Ellevest Inc first reported a position in ETNB in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 50 funds tracked by Wall St. Rank hold ETNB as of Q4 2021.

  • Ellevest Inc reported no remaining 89bio position as of Q4 2021 after selling out during the quarter.
  • Ellevest Inc sold 3 89bio shares in Q4 2021.
  • Ellevest Inc first reported a position in 89bio in Q3 2021 and held it in 1 quarter.
  • Ellevest Inc's 89bio position peaked at $0 in Q3 2021.
  • 50 funds tracked by Wall St. Rank held 89bio as of Q4 2021.

Based on Ellevest Inc's 13F filing for Q4 2021, filed 24 Jan 2022.